Kirby McInerney LLP announced an investigation into HCA Healthcare over potential violations of federal securities laws. The investigation follows HCA Healthcare's July 14, 2026, preliminary second-quarter results, which sharply lowered full-year 2026 profit guidance due to an unfavorable payer mix shift driven by increased uninsured volume, impacting revenue by approximately $400 million in the quarter. The company now forecasts 2026 earnings between $28.70 and $30.50 per share, narrowed its revenue target to $77 billion to $79.5 billion, and adjusted its EBITDA target to between $15.4 billion and $16.1 billion. On the news, HCA Healthcare's stock fell $27.14 per share, or 6.95%, to close at $363.60. The law firm is investigating whether senior management engaged in unlawful business practices, and no lawsuit has been filed at this stage.
HCA Healthcare, Inc.HCA lowered full-year profit guidance due to unfavorable payer mix shift, causing stock to fall 6.95%; law firm investigates potential securities fraud.